Ovarian Cancer

Inherited BRCA mutations improve treatment response and survival

Published in Women's Health Weekly, May 22nd, 2003

In the last decade, much attention has focused on the gene abnormalities linked to certain diseases. Wide attention, for example, has focused on hereditary mutations of the BRCA genes, which can lead to the development of breast and ovarian cancer.

But in recent years, researchers have also learned that ovarian cancer patients who inherit BRCA mutations may live longer than patients who do not. The reason for this survival advantage, however, has not been identified.

Now, researchers at Cedars-Sinai Medical Center have found that improved survival among patients with hereditary BRCA-associated ovarian cancer may result from a greater sensitivity and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2003-05-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry